TY  - JOUR
AU  - González Gil, Inés
AU  - Zian, Debora
AU  - Vázquez Villa, Henar
AU  - Ortega Gutiérrez, Silvia
AU  - López Rodríguez, María L.
PY  - 2015
DO  - 10.1039/c4md00333k
SN  - 2040-2503 (Print) , 2040-2511 (Online)
UR  - https://hdl.handle.net/20.500.14352/34958
T2  - Medicinal Chemical Communications
AB  - Lysophospholipids are lipid molecules that are receiving growing attention because, in addition to their structural function in the cell membrane, they are now regarded as important regulators for diverse biological functions through activation of...
LA  - eng
M2  - 13
PB  - Royal Society of Chemistry (UK)
KW  - EMTREE drug terms: am 095
KW  - am 966
KW  - bms 986020
KW  - digoxin
KW  - flurbiprofen
KW  - G protein coupled receptor
KW  - ki 16425
KW  - lysophosphatidic acid receptor
KW  - membrane phospholipid
KW  - montelukast
KW  - protein LPA1R
KW  - receptor blocking agent
KW  - receptor subtype
KW  - sar 100842
KW  - unclassified drugEMTREE medical terms: cell migration
KW  - cell proliferation
KW  - cell survival
KW  - drug design
KW  - drug development
KW  - drug potentiation
KW  - drug receptor binding
KW  - drug screening
KW  - drug structure
KW  - fibrosing alveolitis
KW  - human
KW  - lipid degradation
KW  - medicinal chemistry
KW  - membrane structure
KW  - neurologic disease
KW  - nonhuman
KW  - phase 1 clinical trial (topic)
KW  - phase 2 clinical trial (topic)
KW  - phospholipid synthesis
KW  - protein function
KW  - Review
KW  - signal transduction
KW  - structure analysis
KW  - systemic sclerosis
KW  - tissue distribution
TI  - The status of the lysophosphatidic acid receptortype 1 (LPA1R)
TY  - journal article
VL  - 6
ER  -